Our website uses cookies which are small bits of data stored as text files on your device. We use these cookies as described in our cookie policy. You can disable or change your cookie settings at any time but parts of our site will not function correctly without them.

IncyteCARES is a program for residents of the United States and US territories.

IncyteCARES for PEMAZYRE

WE’RE HERE TO HELP DURING YOUR TREATMENT WITH PEMAZYRE

At IncyteCARES for PEMAZYRE, our mission is to help you get started with your medicine and to provide information and resources throughout your treatment.

PEMAZYRE prescriptions are filled exclusively through Biologics by McKesson specialty pharmacy. Biologics will work with you and your caregivers to ensure you have the support you need during treatment with PEMAZYRE.

FOR ELIGIBLE PATIENTS, OUR TEAM CAN PROVIDE:

  • Help with understanding your insurance coverage
  • Pharmacy outreach call when you start PEMAZYRE
  • Flexibly scheduled follow-up calls from a pharmacy care team specialist to fit your needs
  • Information about your medicine and condition
  • Text message refill reminders
  • Referrals to advocacy and support organizations
  • Financial assistance options
phone icon

QUESTIONS?

Call IncyteCARES at: 1-855-452-5234, Monday through Friday, 8 am–8 pm ET

FINANCIAL ASSISTANCE OPTIONS FOR PEMAZYRE

copay card

FOR ELIGIBLE PATIENTS WITH COMMERCIAL OR PRIVATE PRESCRIPTION INSURANCE
IncyteCARES for PEMAZYRE COPAY/COINSURANCE PROGRAM

Eligible patients can receive PEMAZYRE for as little as $0, subject to certain limits*

Image of a Patient Copay/Coinsurance Assistance Card

To qualify, you must:

  • Have commercial or private prescription drug coverage. Patients insured under federal or state government prescription drug programs—including Medicare Part D, Medicare Advantage, Medicaid, or TRICARE—are not eligible. Patients without prescription drug coverage are also not eligible
  • Be a resident of the United States or a US territory
  • Have a valid prescription for PEMAZYRE for an FDA-approved use

*Amount of savings on PEMAZYRE will not exceed $9,000 per claim and $25,000 per year. Uninsured, cash-paying patients are not eligible. Not valid for patients insured through Medicare Part D, Medicare Advantage, Medicaid, and TRICARE or any state medical or pharmaceutical assistance program. Valid prescription for PEMAZYRE for an FDA-approved indication is required. Please see complete Terms and Conditions or call IncyteCARES.

HOW TO ENROLL

You can either:

  1. Call IncyteCARES at: 1-855-452-5234 Monday through Friday, 8 am–8 pm ET.

    A representative will ask a few questions. If you are eligible, your program information will be recorded so you can begin receiving PEMAZYRE for as little as $0 per copay/coinsurance.

  2. Ask your Healthcare Professional to enroll you in the Copay/Coinsurance Program.

Graphic representation of 2 people

FOR ELIGIBLE PATIENTS WHO ARE UNINSURED OR UNDERINSURED FOR PEMAZYRE
IncyteCARES for PEMAZYRE PATIENT ASSISTANCE PROGRAM

Eligible patients can receive PEMAZYRE free of charge

The IncyteCARES for PEMAZYRE Patient Assistance Program (PAP) helps eligible patients who do not have prescription drug insurance or who have an insurance plan that will not cover their PEMAZYRE treatment.

To qualify, you must:

  • Be a resident of the United States or a US territory
  • Have a valid prescription for PEMAZYRE for an FDA-approved use
  • Meet certain household size and annual income criteria, including earning less than $125,000 per year or less than 600% of the Federal Poverty Level (whichever amount is higher)
  • Patients with prescription coverage through government programs—including Medicare Part D, Medicare Advantage, Medicaid, TRICARE—or by a healthcare exchange plan are not eligible

HOW TO APPLY

You can either:

  1. Call IncyteCARES at: 1-855-452-5234 Monday through Friday, 8 am–8 pm ET.

    To start, we’ll ask you a few questions to help determine your eligibility for this program. Based on your answers, we will notify you within 2 business days if you qualify for conditional approval. That means you’re approved for a supply of free medicine for 90 days.

    In the meantime, you must send us proof of your current household income. It can be one of the following: your most recent federal income tax return, your most recent W-2 earnings statement from your employer, or one month of your recent pay stubs. Once we review your income information, we’ll notify you if you are fully approved for the IncyteCARES Patient Assistance Program and can continue to receive PEMAZYRE for free.

  2. Ask your Healthcare Professional to submit an application form for you.

Terms and conditions apply. Terms of this program may change at any time.
Calendar

FOR PATIENTS WHOSE INSURANCE COVERAGE FOR PEMAZYRE IS DELAYED
IncyteCARES for PEMAZYRE TEMPORARY ACCESS PROGRAM

Eligible patients may be able to receive a free short-term supply of PEMAZYRE

If you have been prescribed PEMAZYRE for an FDA-approved use and you experience a delay in coverage, we may be able to provide a free 30-day supply of medicine. To be eligible, you must submit a proof of insurance claim verifying the delay. Free product is offered to eligible patients without any purchase contingency or other obligation.

To qualify, you must:

  • Have commercial or private prescription drug coverage or a healthcare exchange plan. Patients insured under federal or state government prescription drug programs—including Medicare Part D, Medicare Advantage, Medicaid, or TRICARE—are not eligible. Patients without prescription drug coverage are also not eligible
  • Be a resident of the United States or a US territory
  • Have a valid prescription for PEMAZYRE for an FDA-approved use
  • Provide proof of the submitted claim and coverage delay. This may be a notice you receive from your insurance company
Terms and conditions apply. Terms of this program may change at any time.

HOW TO APPLY

You can either:

  1. Call IncyteCARES at: 1-855-452-5234 Monday through Friday, 8 am–8 pm ET.

  2. Ask your Healthcare Professional to submit an application form for you.

INDICATIONS AND USAGE

PEMAZYRE is a prescription medicine that is used to treat adults with bile duct cancer (cholangiocarcinoma) that has spread or cannot be removed by surgery:

  • who have already received a previous treatment, and
  • whose tumor has a certain type of abnormal "FGFR2” gene

Your healthcare provider will test your cancer for a certain type of abnormal FGFR2 gene and make sure that PEMAZYRE is right for you.

It is not known if PEMAZYRE is safe and effective in children.

PEMAZYRE is approved based on tumor response and duration of response. There are ongoing studies to show whether PEMAZYRE can improve survival or symptoms.

IMPORTANT SAFETY INFORMATION

Before you take PEMAZYRE, tell your healthcare provider about all of your medical conditions, including if you:

  • have vision or eye problems
  • have problems swallowing tablets
  • are pregnant or plan to become pregnant. PEMAZYRE can harm your unborn baby or cause loss of your pregnancy (miscarriage). You should not become pregnant during treatment with PEMAZYRE.

    Females who can become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with PEMAZYRE.
    • You should use an effective method of birth control during treatment and for 1 week after your final dose of PEMAZYRE. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think that you may be pregnant.

    Males with female partners who can become pregnant:

    • You should use effective birth control when sexually active during treatment with PEMAZYRE and for 1 week after your final dose of PEMAZYRE.
  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 1 week after your final dose of PEMAZYRE.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of PEMAZYRE?

PEMAZYRE may cause serious side effects, including:

  • Eye problems. Certain eye problems are common with PEMAZYRE but can also be serious. Eye problems include dry eye or inflamed eyes, inflamed cornea (front part of the eye), increased tears, and a disorder of the retina (an internal part of the eye). You will need to see an eye specialist for a complete eye exam before you begin treatment with PEMAZYRE, every 2 months for the first 6 months, and then every 3 months during treatment with PEMAZYRE.
    • You should use artificial tears or substitutes, hydrating or lubricating eye gels as needed, to help prevent or treat dry eyes.
    • Tell your healthcare provider right away if you develop any changes in your vision during treatment with PEMAZYRE, including: blurred vision, flashes of light, or see black spots. You may need to see an eye specialist right away.
  • High phosphate levels in your blood (hyperphosphatemia). Hyperphosphatemia is common with PEMAZYRE but can also be serious. Your healthcare provider will check your blood phosphate levels during treatment with PEMAZYRE.
    • Your healthcare provider may prescribe changes in your diet or phosphate lowering therapy, or change, interrupt, or stop PEMAZYRE if needed.
    • Tell your healthcare provider right away if you develop any muscle cramps, or numbness or tingling around your mouth.

The most common side effects of PEMAZYRE include:

  • hair loss
  • diarrhea
  • nails separate from the bed or poor formation of the nail
  • feeling tired
  • change in sense of taste
  • nausea
  • constipation
  • mouth sores
  • dry eyes
  • dry mouth
  • decrease in appetite
  • vomiting
  • joint pain
  • stomach-area (abdominal) pain
  • low phosphate in blood
  • back pain
  • dry skin

These are not all the possible side effects of PEMAZYRE. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects.

You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Incyte Medical Information at 1-855-463-3463.

General information about the safe and effective use of PEMAZYRE.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use PEMAZYRE for a condition for which it is not prescribed. Do not give PEMAZYRE to other people, even if they have the same symptoms you have. It may harm them. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information that is written for healthcare professionals. Keep PEMAZYRE and all medicines out of the reach of children.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.